Global beta glucan market was valued at US$ 551.4 Mn in 2022, exhibiting a CAGR of 8% in terms of revenue, over the forecast period (2023 to 2030) to reach US$ 1,020.6 Mn by 2030.
Report Coverage |
Report Details |
Base Year: |
2022 |
Market Size in 2023: |
US$ 551.4 Mn |
Historical Data for: |
2018 to 2021 |
Forecast Period: |
2023 - 2030 |
Forecast Period 2023 to 2030 CAGR: |
8.00% |
2030 Value Projection: |
US$ 1,020.6 Mn |
There are a number of foods high in beta glucan including: barley fiber, oats and whole grains, reishi, maitake and shiitake mushrooms, seaweed, and algae. Beta glucan is used as medicine. It is most commonly used for heart disease and high cholesterol.
Market Dynamics
R&D in beta-glucan is expected to propel growth of the global beta-glucan market over the forecast period. For instance, in August 2021, Ceapro Inc. collaborated with the Boston-based, Angiogenesis Foundation, a scientific organization, for Beta Glucan and Avenanthramides. Major players operating in the global beta-glucan market are focused on adoption various strategies to enhance their market share. For instance, in June 2020, Biotec Pharmacon officially rebranded to ArcticZymes Technologies.
Key features of the study:
- This report provides an in-depth analysis of the global beta-glucan market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global beta-glucan market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Associated British Foods Plc, Biotec Pharmacon ASA (Biotec BetaGlucans AS), Biothera, the Immune Health Company, Ceapro Inc., Immuno Medic AS, Koninklijke DSM N.V., Super Beta Glucan (SBG) Inc., Groupe Soufflet S.A (AIT Ingredients), Tate & Lyle plc. (Tate & Lyle Oats Ingredients), and Zilor Inc. (Biorigin)
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global beta-glucan market
Detailed Segmentation:
- Global Beta-Glucan Market,By Source :
- Global Beta-Glucan Market, By Application:
- Food & Beverages
- Bakery Products
- Health & Dietary Supplements
- Dairy & Frozen Products
- Cosmetics & Personal Care
- Others
- Global Beta-Glucan Market, By Region:
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
- Company Profiles
- Associated British Foods Plc
- Biotec Pharmacon ASA (Biotec BetaGlucans AS)
- Biothera
- The Immune Health Company
- Ceapro Inc.
- Immuno Medic AS
- Koninklijke DSM N.V.
- Super Beta Glucan (SBG) Inc.
- Groupe Soufflet S.A (AIT Ingredients)
- Tate & Lyle plc. (Tate & Lyle Oats Ingredients)
- Zilor Inc. (Biorigin)